Ganglioside GM3
lipidGM3 ganglioside modulates immune cell and platelet activation during atherosclerotic plaque inflammation and thrombotic responses.
Pathway placement
Cascade stepPlaque inflammation
Confidencelow
RationaleGanglioside modulates immune cell activation in atherosclerotic lesions.
Also acts inPlatelet activation
Druggability
Not assessed (no mapped human gene target).
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma (EDTA to limit oxidation)
Collection tube
K2/K3-EDTA (lavender-top) · Serum separator (gold/red-top, SST)
Method / principle
LC-MS/MS lipidomics (targeted or shotgun)
Reagent / substrate
Deuterated lipid-class internal standards; MS/MS transitions
Platform
LC-MS/MS
Turnaround · availability
Research · Research-only
Literature evidence(1)
- Empagliflozin restores cardiac metabolism and suppresses immune activation in acute myocardial infarction.Atherosclerosis · 2025 · PMID 40543297 · doi